Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells-Reference-Cited by-同舟云学术

Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells

Published:1994-08 Issue:4 Volume:48 Page:827-835
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Pan Xiaolel,Arauz Elizabeth,Krzanowski Joseph J.,Fitzpatrick David F.,Polson James B.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference43 articles.

1. Cellular interactions, growth factors and smooth muscle cell proliferation in atherogenesis;Ross;Ann NY Acad Sci,1990

2. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation;Ip;J Am Coll Cardiol,1990

3. Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells;Jonzon;J Cell Physiol,1985

4. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2; in cultured rabbit aortic smooth muscle cells;Morisaki;Atherosclerosis,1988

5. Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1;Loesberg;Exp Cell Res,1985

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-Analysis of Efficacy and Safety of Cilostazol Prescription in Patients With Femoropopliteal Peripheral Artery Disease After Endovascular Therapy;Journal of Endovascular Therapy;2024-04-09

2. Discovery of 2-(Methylcarbonylamino) thiazole as PDE4 inhibitors via virtual screening and biological evaluation;Journal of Molecular Graphics and Modelling;2023-11

3. Molecular basis of stroke;Clinical Molecular Medicine;2020

4. Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP;Cells;2019-11-16

5. Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study;Frontiers in Pharmacology;2019-01-07